Marketed oral and injectable non-insulin antidiabetic agents (Figure 2) have been demonstrated to be effective but they possess several adverse effects that contribute to consider the diabetes treatment approach with no adverse effects a challenge. This evidence concerns the gene INS and diabetes mellitus.